Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$10.32 - $17.28 $1.24 Million - $2.07 Million
119,972 New
119,972 $1.3 Million
Q3 2021

Nov 15, 2021

SELL
$21.01 - $27.64 $1.48 Million - $1.95 Million
-70,492 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$23.49 - $35.8 $4.18 Million - $6.37 Million
-177,974 Reduced 71.63%
70,492 $1.84 Million
Q1 2021

May 17, 2021

BUY
$25.79 - $39.02 $6.41 Million - $9.7 Million
248,466 New
248,466 $8.77 Million

Others Institutions Holding ALLO

About Allogene Therapeutics, Inc.


  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $326M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Moore Capital Management, LP Portfolio

Follow Moore Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Moore Capital Management, LP with notifications on news.